Endpoints and Measurements
Cross-source consensus on Endpoints and Measurements from 1 sources and 4 claims.
1 sources · 4 claims
Other
Highlighted claims
- The primary endpoint is change from baseline to Day 1 in PSG-measured total sleep time. — Daridorexant in children and adolescents with insomnia disorder: study protocol for a multicentre randomised controlled trial
- Pharmacokinetic assessment includes next-morning plasma concentration for all participants and more detailed parameters in the sub-study. — Daridorexant in children and adolescents with insomnia disorder: study protocol for a multicentre randomised controlled trial
- Exploratory endpoints include PSG, sleep diary, PROMIS, global assessment, and actigraphy measures. — Daridorexant in children and adolescents with insomnia disorder: study protocol for a multicentre randomised controlled trial
- Palatability and acceptability are assessed using 5-point taste and swallowability scales. — Daridorexant in children and adolescents with insomnia disorder: study protocol for a multicentre randomised controlled trial